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Over a 30-year period, 17 patients below the age of 35 with invasive squamous carcinoma 
of the vulva were identified, 8 of whom (47.1%) had “microinvasive” disease. Venereal 
diseases and condyloma accuminata were not predisposing factors. Immunosuppression 
was a contributory factor in 2 patients. Although carcinoma in situ was antecedent in only 
1 patient, it was an associated lesion in 87.5% of patients with “microinvasive” and 22.2% 
of patients with invasive carcinoma. The nature and course of this disease in young patients 
do not differ from the elder counterpart. Prolonged follow-up of these patients has revealed 
increased susceptibility of the perineum, vagina, and cervix to multiple neoplasms. 
INTRODUCTION 
Invasive squamous carcinoma of the vulva is a disease classically afflicting 
the aged beyond the fifth and sixth decade who are often obese, hypertensive, 
and diabetic [1,2]. Reports of larger series of cases pointed to the paucity of 
patients below the age of 35 [1,3,4]; the youngest patient documented was 14 
[5]. Earlier reports also suggested that venereal diseases could be predisposing 
factors in invasive vulvar carcinoma in patients who are younger than the average 
age [6-81. In addition, patients with condyloma accuminata of the vulva [9-l 11, 
or those immunosuppressed [ 12,131 may also develop invasive vulvar carcinoma 
at a younger age. 
Lately, carcinoma in situ of the vulva appears to be on the rise in young 
females [ 11,14,15]. Biologically and histopathologically, vulvar carcinoma is said 
to be dissimilar to carcinoma of the cervix [16]; this implication, and whether 
the in-situ carcinoma has any bearing on the invasive counterpart, is uncertain. 
Increasing attention has also been focused on the so-called early, superficially 
invasive, or “microinvasive” vulvar carcinoma [17-191. The question of a con- 
tinuum from in situ disease and the question of metastasis are also uncertain. 
Regardless of the above, invasive carcinoma of the vulva when found in the 
young is a serious disease. The surgical treatment is mutilating, and its emotional 
and psychological repercussions are immense. This has prompted considerations 
of less radical operations in selected young patients who have early invasive 
carcinoma [18]. This study was undertaken to determine whether any predis- 
posing factors or associated conditions exist in young patients with invasive 
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carcinoma and whether its course of events is different from that of the older 
age group. 
MATERIALS AND METHODS 
From January 1950 through December 1979, 515 patients with a malignancy 
of the vulva were seen at the University of Michigan Hospital. Sixty-three 
patients were below the age of 35, and the youngest was 18. Forty-two of them 
had carcinoma in situ and the remaining 21 had the following malignancies: 
invasive squamous carcinoma-17, malignant melanoma-2, leiomyosarcoma- 
1, and Bartholin gland carcinoma-l. The 17 patients with invasive squamous 
vulvar carcinoma were analyzed in detail with regard to age and parity, pre- 
sentation, associated conditions, treatment, and follow-up status. The patholog- 
ical slides were reviewed, noting also the areas adjacent to the lesion. Staging 
of the disease was made according to the current criteria of the International 
Federation of Gynaecology and Obstetrics [20]. Early invasion or “microinva- 
sion” was defined as invasion beyond the basal layer of the epidermis of not 
more than 5 mm in depth from the surface of the lesion, with or without an 
overlying epithelium. Survivors following radical vulvectomy were interviewed 
to evaluate their psychological sequelae following surgery. They were asked 
about their comprehension of the surgery, the impact of the surgery on their 
bodily image and sexual rehabilitation, and the attitudes of their sexual partner. 
RESULTS 
The age of the patients ranged from 23 to 35 (mean, 28 years). Parity ranged 
from 0 to 8 (average, 3.2). The most common symptom was pruritus, present 
in 8 patients, and 2 patients were asymptomatic. The lesion was described as 
a tumor in 10, ulcer in 5, and leukoplakia in 2. In 4 patients with a growth, a 
white lesion adjacent to the growth was also seen. One patient was originally 
diagnosed as having lichen sclerosus et atrophicus for 4 months until a growth 
was discovered. In 1 other patient, the growth had the appearance of lympho- 
granuloma venereum, but a Frei test was inconclusive. Obesity and hypertension 
were not found, but 1 patient had diabetes of juvenile onset, and she also had 
Fanconi’s syndrome as well as proven immunodeficiency as a result of repeated 
episodes of pulmonary infections. One patient had Hodgkin’s disease, treated 
initially with irradiation and subsequently with chemotherapy for recurrent dis- 
ease. A history of vulvar carcinoma in situ prior to invasive carcinoma was 
elicited in one patient with a 6-year interim period. With respect to the onset 
of symptoms to diagnosis, patient delay was found to average 10 months, while 
physician delay in diagnosis averaged 16 months, for in many of these patients 
cancer was not suspected at all. 
The treatment modalities in both the early invasive and invasive carcinoma 
are as shown in Table 1. Age was always a consideration in the decision on 
individual treatment; this was more so in recent years. The conventional radical 
vulvectomy and groin lymphadenectomy was employed in 3 of 8 patients with 
early invasive, and 8 of 9 patients with frank invasive carcinoma. Among those 
with invasive carcinoma, 6 had Stage I, 2 Stage II, and 1 Stage III disease. One 
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TABLE 1 
TREATMENT MODALITIES IN PATIENTS WITH EARLY INVASIVE AND FRANK INVASIVE CARCINOMA OF 
THE VULVA 
Early 
invasive carcinoma Invasive carcinoma 
RV, GLND” 3 7 
RV, GLND, PLND - 1 
TV, GLND - 1 
Wide excision, GLND 1 - 
Subtotal vulvectomy 3 - 
No treatment 1 - 
Total 8 9 
a RV, radical vulvectomy; TV, total vulvectomy; GLND, groin lymph node dissection; PLND, 
pelvic lymph node dissection. 
patient with an invasive carcinoma less than 2 cm in size was treated with only 
a total vulvectomy and groin lymphadenectomy. In patients with early invasive 
disease, it was noted that 3 had subtotal vulvectomy alone, and 1 had a wide 
excision of the vulvar lesion with bilateral groin lymphadenectomy. One patient 
with early invasive disease had her treatment withheld in view of advanced 
Hodgkin’s disease. 
The associated pathological findings are as shown in Table 2. Carcinoma in 
situ was found at the margin of the lesion in 7 of 8 patients (87.5%) with early 
invasive carcinoma and 2 of 9 patients (22.2%) with invasive carcinoma. Three 
of nine patients (33.3%) with invasive carcinoma had surrounding lichen sclerosis, 
but without associated atypia or hyperplasia. 
Follow-up of these patients has revealed that 7 had developed a recurrence 
or a new primary carcinoma many years after treatment. The sites included 
urethral meatus, vagina, cervix gluteal skin, and perineum (Table 3). 
In patients who had early invasive carcinoma, 4 deaths occurred from non- 
related causes, this includes the patient who had Hodgkin’s disease. The re- 
maining 4 patients are alive with no evidence of disease from 1 to 17 years. Of 
the patients with invasive carcinoma, one death occurred in a 28-year-old patient 
who had a Stage III undifferentiated carcinoma with metastasis to the pelvic 
nodes. Despite surgery and pelvic irradiation, she died 8 months later. Three 
other patients also died, all without disease and more than 10 years following 
treatment. Four patients are presently alive without disease from 4 to 22 years. 
TABLE 2 
ASSXIATED PATHOLOGY AT THE MARGIN OF LESIONS 
No. 
Associated with Associated with 
lichen sclerosis CIS 
Early invasive Ca 
Frank invasive Ca 
8 - 7(87.5%) 
9 3(33.3%) 2(22.2%) 
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TABLE 3 
TYPE AND INTERVAL OF NEW LESIONS FOLLOWING TREATMENT OF VULVA CA IN SEVEN PATIENTS 
Vulvar Ca- 
early invasive 
CIS gluteal skin 










Invasive Ca vagina 
Invasive squamous Ca 
cervix 









Six patients were interviewed on their thoughts regarding radical vulvectomy. 
All appeared to have sufficient understanding of the surgery initially. Five patients 
expressed some regrets about the surgery, realizing though the intent was cure 
of their disease. One thought that surgery to rid her of the unbearable pruritus 
was the most important reason for undergoing the surgery. All, however, wished 
that surgery could be less disfiguring. When compared with mastectomy, radical 
vulvectomy appeared to be less traumatic to their bodily image. Readjustment 
following surgery was not difficult in the majority of patients. One patient took 
more than a year to accept surgical ablation of her external genitalia. Another 
patient, even 8 years after surgery, has persistent suicidal thoughts requiring 
regular psychiatric consultations and treatment. In terms of sexual functions, all 
but one patient reported no significant decrease in libido. As regard orgasmic 
feeling during sexual intercourse, three reported no difference; two had dimin- 
ished sensation, and in one patient, it was absent. Surgery had no effect on the 
sexual attitudes of their partner. One patient did complain of difficult intercourse 
as a result of introital stenosis, but a suggested vaginoplasty was refused by the 
patient concerned. None of the six patients interviewed had any significant 
bladder or bowel dysfunction following surgery. 
DISCUSSION 
Invasive squamous carcinoma of the vulva is a rare disease in young patients 
below the age of 35, and comprised only 3.3% of patients with malignancies of 
the vulva seen at the University of Michigan Hospital over a 30-year period. Its 
occurrence in young patients must, however, be recognized, for the preinvasive 
as well as the early invasive carcinoma are being seen more frequently in young 
patients. 
Venereal disease was found not to be a predisposing factor in this group of 
patients, contrary to older reports [6-81, although in one patient, lymphogran- 
uloma venereum could not definitely be excluded. 
Lichen sclerosis was found to be a significant associated lesion in three of nine 
patients (33.3%) with invasive carcinoma but not in patients with early invasive 
carcinoma. In these patients, no hyperplasia or atypia was found to imply a 
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cause-effect relationship. In general, lichen sclerosis is said to be an associated 
lesion in 3 to 4% of patients with invasive squamous vulvar carcinoma [16,19,21]. 
It is unusual for lichen sclerosis to progress to invasive carcinoma unless hy- 
perplasia and atypia occurred. Hart [21] reported only 1 case in an analysis of 
107 patients with lichen sclerosus et atrophicus. Conversely, it is more usual for 
the vulvar dystrophy of the hyperplastic type to be associated with invasive 
vulvar carcinoma [16,22]. 
It is tempting, in vulvar carcinoma, to postulate a continuum of the neoplastic 
process from in situ carcinoma through microinvasion to frank invasion. Such 
a sequence of events has not been proven on definite grounds. Friedrich [23] 
reported 5 cases out of 50 patients with carcinoma in situ progressing to invasion; 
Buscema [13] also reported 5 such patients, and a case each was reported by 
Tovell [24] and Jones [25]. In this series of patients, only 1 patient had carcinoma 
in situ antecedent to an early invasive carcinoma. Immunosuppression has been 
suggested to be a predisposing cause for carcinoma in situ of the vulva progressing 
to invasive disease in young patients [13]. This relationship, if true, is present 
in one of our patients, and possibly in another who was probably immunosup- 
pressed as a result of treatment for Hodgkin’s disease. 
It is a significant finding that 88.9% of the early invasive and 22.2% of the 
overt invasive vulvar carcinoma had associated carcinoma in situ. The carcinoma 
in situ bordering frank invasive vulvar carcinoma was often abrupt, while that 
associated with early invasion was often extensive, merging with the focus or 
foci of microinvasion. In general, it is said that carcinoma in situ occurs at the 
margins of invasive vulvar carcinoma in approximately 20% of cases [16,19]. The 
high incidence of concomitant carcinoma in situ in early invasive vulvar carci- 
noma is striking. Barnes [26] suggested that there are two types of microinvasive 
vulvar carcinoma: one is associated with extensive overlying carcinoma in situ, 
and the other is seldom associated with in situ disease but tends to metastasize. 
Young patients with invasive vulvar carcinoma do not appear to have a more 
advanced disease when first diagnosed or to have a different course of the disease 
compared to their elderly counterparts. In this series of patients, none of those 
who had early invasive carcinoma died of her disease, and in those who had 
groin lymphadenectomy, no lymph node metastasis was detected. In patients 
with invasive carcinoma, only one death was recorded attributable to progressive 
disease. 
The young age of these patients when their disease was first diagnosed made 
study of their long term follow-up possible. Seven of seventeen patients (42.2%) 
had developed a new lesion in the lower genital region 4 to 20 years after initial 
treatment. In many of these patients, the new lesion appears to be new primary 
lesion rather than recurrence of the original vulvar carcinoma. One must be 
aware that the new perineum after vulvectomy, the cervix and the vagina are 
all potential sites for the development of multiprimary neoplasms [27]. 
The treatment of young patients with invasive vulvar carcinoma should take 
into consideration their age and the potential mental trauma. The postvulvectomy 
syndrome may persist for a long interval and may even lead to suicidal inclination 
in the extreme as exemplified by one such patient. These patients should rightly 
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be subjected to extensive counseling before surgery. In addition, a sympathetic 
and compassionate approach with constant reassurances are all essential elements 
toward rehabilitating these patients. A less radical approach is recommended in 
treating young patients with early invasive carcinoma if the lesion is less than 
2 cm, without evidence of total anaplasia or vascular permeation [17]. An even 
more conservative approach as advocated by Di Saia [ 181, consisting of sampling 
the superficial inguinal nodes and performing a wide excision of the vulvar lesion 
only if the frozen section of the lymph nodes are negative, may also be considered 
in selected patients. 
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